Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, has seen its stock tumble to $42.05, trading near its 52-week low. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value calculation, with analysts setting price targets ranging from $46 to $120. This significant drop reflects a stark contrast to the company’s performance, with Celanese experiencing a -70.64% return over the past year. While current market challenges persist, InvestingPro data reveals positive indicators, including expected net income growth and a 21-year track record of maintaining dividend payments. The current price level presents a critical juncture for Celanese, as market participants consider the company’s future prospects, with analysts forecasting earnings per share of $5.36 for FY2025. For deeper insights into CE’s valuation and technical indicators, explore the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Celanese Corporation has made significant financial and strategic moves. The company announced the issuance of senior notes totaling $1.8 billion, with $700 million in 6.500% Senior Notes due 2030 and $1.1 billion in 6.750% Senior Notes due 2033, alongside €750 million in 5.000% Senior Notes due 2031. This financing is aimed at strengthening Celanese’s financial position and supporting its business operations. Additionally, Celanese has amended its bylaws to streamline litigation processes related to securities laws, designating specific courts for legal proceedings, which reflects the company’s effort to manage legal risks effectively.
In another development, Celanese plans to increase prices for several chemical products in the Western Hemisphere, including vinyl acetate monomer and vinyl-based emulsions, effective March 17, 2025. These adjustments are a response to changing market conditions. On the analyst front, Evercore ISI has revised its price target for Celanese to $75 from $85, maintaining an In Line rating, while Piper Sandler has lowered its target to $50 from $77, keeping an Underweight rating. Piper Sandler’s adjustment follows a reassessment of Celanese’s fourth-quarter and full-year results for 2024, along with its guidance for 2025. The firm cites challenges in Celanese’s financial recovery and has significantly reduced its EBITDA estimates for the coming years.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.